Hepatobiliary & Pancreatic Diseases International

Papers
(The H4-Index of Hepatobiliary & Pancreatic Diseases International is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management36
Recent advances in immunotherapy for hepatocellular carcinoma34
Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study32
SNHG16 promotes hepatocellular carcinoma development via activating ECM receptor interaction pathway30
Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study30
Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway28
Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review26
ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway25
Mitochondria: A critical hub for hepatic stellate cells activation during chronic liver diseases22
Robotic surgery and liver transplantation: A single-center experience of 501 robotic donor hepatectomies22
Application of machine learning models for predicting acute kidney injury following donation after cardiac death liver transplantation21
Navigated liver surgery: State of the art and future perspectives20
Uses of a dedicated 3D reconstruction software with augmented and mixed reality in planning and performing advanced liver surgery and living donor liver transplantation (with videos)19
Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: A systematic review and network meta-analysis17
Artificial intelligence and liver transplantation: Looking for the best donor-recipient pairing16
Complications of modern pancreaticoduodenectomy: A systematic review and meta-analysis16
Biomarkers for response to immunotherapy in hepatobiliary malignancies16
The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional s16
Presentation and surgical management of xanthogranulomatous cholecystitis16
The latest research progress on minimally invasive treatments for hepatocellular carcinoma16
0.030084133148193